Dr Steven A Kong, PHARM D in San Quentin, CA - Pharmacist

Dr Steven A Kong, PHARM D is a Pharmacist based in San Quentin, California. Dr Steven A Kong is licensed to practice in California (license number RPH46304) and his current practice location is 1 Main St, San Quentin, California. He can be reached at his office (for appointments etc.) via phone at (415) 454-1460.

NPI number for Dr Steven A Kong is 1801166053 and his current mailing address is Po Box 77, San Quentin, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1801166053.

Contact Information

	Dr Steven A Kong, PHARM D
	1 Main St, San Quentin, CA 94964-1000
	(415) 454-1460
	Not Available

Healthcare Provider's Profile

Full Name	Dr Steven A Kong
Gender	Male
Speciality	Pharmacist
Location	1 Main St, San Quentin, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1801166053
Provider Enumeration Date: 01/05/2012
Last Update Date: 09/21/2016

Medical Identifiers

Medical identifiers for Dr Steven A Kong such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1801166053	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	RPH46304 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Steven A Kong is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Steven A Kong, PHARM D Po Box 77, San Quentin, CA 94964-0077 Ph: (650) 755-6132	Dr Steven A Kong, PHARM D 1 Main St, San Quentin, CA 94964-1000 Ph: (415) 454-1460

News Archive

Breast cancer patients more likely to have joint pain from taking AIs: Study

Breast cancer patients are more likely to have joint pain from taking aromatase inhibitors if they have advanced stage cancer, according to a study presented at the American College of Rheumatology's annual meeting, held Nov. 7-11, in Atlanta. The study is one of the first to identify factors that increase the likelihood that a patient will suffer joint pain from AI therapy.

Selection of therapeutic workshops to be presented at the Twelfth Annual BIO CEO & Investor Conference

"This year's BIO CEO & Investor Conference will provide a unique forum to showcase therapeutic areas with key catalysts – from new and dynamic therapies to cutting edge investment opportunities," said Alan Eisenberg, executive vice president of Emerging Companies & Business Development at BIO.

Researchers reassess supposed link between depression and all-cause mortality

Over three decades of research suggest that depression increases the odds of death. However, a new research paper throws doubt on this presumed link after finding no evidence of a direct association between depression and all-cause mortality.

Baby Jaya receives a pacemaker 15 mins after birth

Little Jaya lived up to her name which in Hindi means victorious. Jaya Maharaj became one of the smallest recipients of a pacemaker when she was just 15 minutes old.

Transcendental Meditation aids students diagnosed with ADHD

A panel of physicians and scientists will report on the benefits of a simple meditation practice for aiding students diagnosed with ADHD during a national medical webinar, which will be hosted by the David Lynch Foundation on Wednesday, September 30, 12 noon (ET).

Dr Steven A Kong, PHARM D - Pharmacist in San Quentin, CA